Related Experiment Video
Updated: May 27, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Ornithine decarboxylase mRNA is stabilized in an mTORC1-dependent manner in Ras-transformed cells
Sofia Origanti1, Shannon L Nowotarski, Theresa D Carr
1Department of Cellular and Molecular Physiology, Penn State College of Medicine, Hershey, PA 17033, USA.
Abstract:
Upon Ras activation, ODC (ornithine decarboxylase) is markedly induced, and numerous studies suggest that ODC expression is controlled by Ras effector pathways. ODC is therefore a potential target in the treatment and prevention of Ras-driven tumours. In the present study we compared ODC mRNA translation profiles and stability in normal and Ras12V-transformed RIE-1 (rat intestinal epithelial) cells. While translation initiation of ODC increased modestly in Ras12V cells, ODC mRNA was stabilized 8-fold. Treatment with the specific mTORC1 [mTOR (mammalian target of rapamycin) complex 1] inhibitor rapamycin or siRNA (small interfering RNA) knockdown of mTOR destabilized the ODC mRNA, but rapamycin had only a minor effect on ODC translation initiation. Inhibition of mTORC1 also reduced the association of the mRNA-binding protein HuR with the ODC transcript. We have shown previously that HuR binding to the ODC 3'UTR (untranslated region) results in significant stabilization of the ODC mRNA, which contains several AU-rich regions within its 3'UTR that may act as regulatory sequences. Analysis of ODC 3'UTR deletion constructs suggests that cis-acting elements between base 1969 and base 2141 of the ODC mRNA act to stabilize the ODC transcript. These experiments thus define a novel mechanism of ODC synthesis control. Regulation of ODC mRNA decay could be an important means of limiting polyamine accumulation and subsequent tumour development.
Insights
Ras activation stabilizes ornithine decarboxylase (ODC) mRNA by 8-fold, primarily through mTORC1 pathway regulation of HuR binding. This discovery offers new strategies for targeting Ras-driven tumors by controlling ODC mRNA decay.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Ras activation significantly induces ornithine decarboxylase (ODC), a key enzyme in polyamine synthesis.
- ODC is implicated in the development and progression of Ras-driven tumors, making it a potential therapeutic target.
Purpose of the Study:
- To investigate the mechanisms controlling ODC mRNA translation and stability in normal versus Ras12V-transformed cells.
- To elucidate the role of the mTORC1 pathway and HuR protein in regulating ODC mRNA stability.
Main Methods:
- Comparison of ODC mRNA translation profiles and stability in normal and Ras12V-transformed RIE-1 cells.
- Treatment with the mTORC1 inhibitor rapamycin and siRNA knockdown of mTOR.
- Analysis of HuR protein association with ODC mRNA and ODC 3'UTR deletion constructs.
Main Results:
- Ras12V transformation led to an 8-fold stabilization of ODC mRNA, with only a modest increase in translation initiation.
- Inhibition of mTORC1 (using rapamycin or siRNA) destabilized ODC mRNA and reduced HuR binding to the ODC transcript.
- Specific regions within the ODC 3'UTR (bases 1969-2141) were identified as critical for mRNA stabilization.
Conclusions:
- A novel mechanism for ODC synthesis control involves the regulation of ODC mRNA decay via the mTORC1 pathway and HuR.
- Targeting ODC mRNA stability presents a potential therapeutic strategy for preventing polyamine accumulation in Ras-driven cancers.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Ras Gene
Ras is a superfamily...
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation

